Department of Hepatobiliary Surgery and Visceral Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
University Children's Hospital, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Liver Transpl. 2019 Jun;25(6):889-900. doi: 10.1002/lt.25423. Epub 2019 Apr 19.
Liver transplantation (LT) has been shown to be a feasible treatment in patients with severe forms of maple syrup urine disease (MSUD). Because of a sufficient extrahepatic enzyme activity in non-MSUD individuals, the organ of MSUD patients can be used as a domino graft. We performed a retrospective data collection of all LTs for MSUD carried out at the University Medical Center Hamburg-Eppendorf (2016-2018). Moreover, data from all consecutive domino LTs of the MSUD grafts either transplanted at our institution or allocated to other transplant centers were analyzed. During the study period, 15 LTs in MSUD patients were performed (12 children, 3 adults; median age, 10.9 years; range, 0.3-26.1 years). Biliary complications occurred in 20%, and 13.3% suffered from bleeding complications. No further surgical problems occurred. At present, all MSUD patients are alive with a well-functioning liver graft and on an unrestricted diet. In total, 14 consecutive domino LTs were performed. No surgical complications requiring intervention occurred. One patient died because of HCC relapse, and all other patients are alive with good liver graft function. In conclusion, the use of MSUD livers as domino grafts is safe and allows application of LT in MSUD patients without net extraction of a liver graft from the limited donor pool.
肝移植(LT)已被证明是治疗严重枫糖尿症(MSUD)患者的一种可行方法。由于非 MSUD 个体中存在足够的肝外酶活性,因此 MSUD 患者的器官可以作为多米诺骨牌移植物使用。我们对汉堡-埃彭多夫大学医学中心(2016-2018 年)进行的所有 MSUD 肝移植进行了回顾性数据收集。此外,还分析了在我们机构或分配给其他移植中心进行的所有连续 MSUD 移植物的多米诺骨牌 LT 的数据。研究期间,对 15 例 MSUD 患者进行了 LT(12 例儿童,3 例成人;中位年龄 10.9 岁;范围 0.3-26.1 岁)。20%发生胆道并发症,13.3%发生出血并发症。没有发生其他手术问题。目前,所有 MSUD 患者均存活,肝脏移植物功能良好,饮食不受限制。总共进行了 14 例连续的多米诺骨牌 LT,没有发生需要干预的手术并发症。1 例患者因 HCC 复发死亡,其他患者均存活,肝脏移植物功能良好。总之,将 MSUD 肝脏作为多米诺骨牌移植物使用是安全的,允许在 MSUD 患者中应用 LT,而不会从有限的供体库中提取肝脏移植物。